Little numerical analysis has been done on in vivo vascular fluorescence imaging. Here, we use a 3D fluorescence Monte Carlo model to evaluate a microvasculature geometry obtained via two-photon microscopy. We found that a bulk-vascularization assumption does not pro-vide an accurate picture of penetration depth of the collected fluorescence signal. Instead the degree of absorption difference between extravascular and intravascular space, and the degree of stokes shift must be taken into account to determine the depth distribution. Additionally, we found that using targeted illumination can provide for superior surface vessel sensi-tivity over wide-field illumination, with small area detection offering an even greater amount of sensitivity to surface vasculature. Depth sensitivity can be enhanced by either increasing the detector area or increasing the illumination area. Finally, we see that excitation wavelength and vessel size can affect intra-vessel sampling distribution, as well as the amount of signal that originates from inside the vessel under targeted illumination conditions.
INTRODUCTION
Fluorescence imaging is a widely used method of measuring functional and structural parameters which cannot be easily imaged using endogenous chromophores. The specific uses of fluorophores and phosphors in-vivo vary widely; a few examples include applications such as molecular imaging, cancer imaging, and functional imaging of hemodynamic properties. 1 Correspondingly, there are a number of delivery methods for fluorophores depending on the application in question.
Several imaging methods require the topical application of fluorophores, and subsequent diffusion through the tissue prior to imaging. An example of this method is voltage sensitive dye (VSD) imaging, which is often used to image changes in membrane potential. 2 When not considering the genetically expressed protein variants, These methods are inherently limited by both the capability of the fluorophore to diffuse through the tissue, and the need to excite the fluorophore and measure the emission through the highly turbid tissue media. However, as these agents distribute themselves in the tissue via diffusion, predicting the distribution of the agent in the tissue can typically be done through the diffusion equation.
Intravascular contrast agents do not suffer from the need to diffuse through tissue. However, imaging is more difficult to model mathematically as the fluorophore is no longer distributed in a smooth gradient, as is generally the assumption in VSD imaging. Several analytical methods have been used to model photon migration in an intravascular fluorescence imaging context. All of these methods treat the tissue as a homogeneous medium, or a series of homogeneous layers, where diffusion determines the depth and resolution of imaging. [3] [4] [5] In the brain, these methods fail to consider the wide variance in absorption between the intra-and extra-vascular space.
The purpose of this work is to analyze two common intravascular contrast agents used to measure hemodynamic parameters in the brain: porphyrin and Indocyanine Green (ICG). Porphyrin-based contrast agents are oxygen sensitive phosphorescent probes which have excitation maximums at 415 and 524nm, and an emission maximum at 690nm. ICG is a fluorescent probe used to image blood flow and clearance, and has an absorption maximum in plasma at approximately 800nm, and an emission maximum at 880nm. The dyes were chosen so that several situations could be studied: visible wavelength excitation with NIR emission, and NIR excitation with NIR emission.
Several methods have been developed to ensure that fluorophore excitation is localized, including using scanning confocal microscopy 6 and a Digital Micromirror Device (DMD). 7 The confocal system confines the photons detected to a small area in the tissue, while the DMD system integrates the photons emitted from a large area on the tissue surface.
We have developed a Monte Carlo model whereby fluorescence emission can be modeled in a realistic in vivo geometry using excitation and detection schemes currently being used. [7] [8] [9] The model is used to determine the differences in fluorescence emission distribution between a realistic microvasculature geometry and a homogeneous tissue geometry. The model is further used to demonstrate the origin of fluorescence emission under several different illumination and detection schemes, and then to study intra-vessel distribution of fluorescence emission based on the excitation wavelength.
3D FLUORESCENCE MONTE CARLO MODEL
The model uses a 3D fluorescence Monte Carlo method to evaluate an illumination and detection scheme in an arbitrary geometry. 10, 11 Geometries are specified by setting tissue optical properties in a 3D voxelized grid. Excitation and emission optical properties can be specified separately for each voxel. The modeled excitation photons scatter through the tissue and can either be absorbed in a voxel, whereby an emission event may occur, or terminated if it reaches the boundary of the geometry. Emission photons originate from the location of absorption and are emitted isotropically. The emitted photons can then either scatter or be absorbed based on an independent set of emission optical properties.
Geometry and optical properties
The optical properties of Pd-porphyrin, ICG, blood and gray matter were used in this model. The Monte Carlo model allowed for an arbitrary 3D voxelized geometry, where each voxel could represent one of up to 255 different sets of optical properties (µ a , µ s , g). Quantum efficiency can be set for the emission optical properties, which determines the likelihood of fluorescence or phosphorescence emission upon absorption of an incident excitation photon.
The model geometry was derived from in vivo images of mouse cortical vasculature. Scanning two-photon fluorescence microscopy was used to generate depth-resolved stacks of microvasculature in a mouse (CD-1; male, 25 -30 g). All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Texas at Austin. The animals were anesthetized by inhalation of 2.3% isoflurane in oxygen through a nose cone. Body temperature was maintained at 37
• C using a feedback controlled heating plate (ATC100, World Precision Instruments, Sarasota, FL, USA) during the experiment. The animals were fixed in a stereotaxic frame (Kopf Instruments, Tujunga, CA, USA) and an 3mm x 3mm portion of the skull was removed using a dental burr (IdealTM Micro-Drill, Fine Science tools, Foster City, CA, USA). 50µL of 5% weight/volume Texas Red (Invitrogen, Eugene, OR, USA) was administered through a retro-orbital injection to label the vasculature. A 500 µm × 500 µm image was taken in 2 µm z-steps down to 400 µm.
The geometry for the Monte Carlo model was then created by filtering the images to smooth out heterogeneities in the vasculature, interpolating to attain images at every 1 µm and thresholding the images to generate a 500 × 500 × 400 voxel binary geometry. Each voxel was assigned a set of excitation and emission optical properties based on whether it represented extravascular or intravascular space. Fig. 1(a) shows the two-photon stack used to generate the geometry.
The intravascular absorption coefficients were generated based on the extinction coefficients of hemoglobin and Pd-porphyrin/ICG. Concentrations of hemoglobin and Pd-porphyrin in the vasculature were assumed to be 2.3 mM 12 and 0.1 mM 7 respectively. The concentration of ICG was 0.13 mM. Scattering coefficients were interpolated from measurements done by Bevilacqua et al 13 and Friebel et al.
14 Extravascular absorption and scattering coefficients were based on the in vitro measurements by Yaroslavsky et al. 15 It was necessary to use in vitro measurements of the extravascular tissue because blood was assumed to only be present in intravascular space. The in vitro measurements were taken in the absence of blood. The scattering coefficients were found to be slightly higher at 800 nm and 880 nm, which is likely an artifact of ex vivo measurements. The quantum efficiency was set to 1 for the intravascular space and 0 for the extravascular space.
Single vessel and homogeneous geometries were also generated. The homogeneous geometries were created by using a 500×500×400 voxel geometry where all voxels were assigned the same properties. Optical properties were assigned by assuming that the only absorber was blood mixed with fluorescent dye, the same assumption made for the intravascular properties in the microvasculature geometry. The properties were then scaled by 0.01, 0.05 and 0.10 to represent a bulk-vascularization assumption of 1%, 5% and 10% respectively. The microvasculature geometry used contained approximately 3.5% vascularization, so the chosen bulk-vasculature amounts of 1%, 5% and 10% provide a range of approximations that can be used for comparison.
The single vessel consisted of a 3mm × 3mm × 3mm cubic geometry with a single vessel running down the top center was created, as shown in Fig. 1(b) . The size of the vessel was varied from 25 µm to 200 µm in 25 µm increments. The intra-vessel optical properties were set according to the values listed in Table 1 . Outside the vessel, the tissue was assumed to be homogeneous with a bulk volume fraction of approximately 5%.
Fluorescence Monte Carlo
A 3D fluorescence Monte Carlo model was used where photons enter the 3D voxelized geometry in a user specified location, beam radius and numerical aperture. Each voxel is assigned optical properties at both the excitation and emission wavelengths. If an excitation photon is absorbed, then a fluorescence photon may be generated depending on the quantum efficiency of the tissue type where the photon was absorbed.
Upon creation, the fluorescence photon is emitted isotropically from the point where the excitation photon was absorbed. The model then uses emission optical properties to specify the scattering and step sizes of the fluorescent photons. Absorption is not calculated at each emission photon move location, but is instead applied during post-processing. 10, 16 For each fluorescence photon that exits the tissue within the specified detector area and NA, the total pathlength traveled in each tissue type is recorded. In post processing, the contribution to the detected signal from photons originating at a point inside the tissue (x, y, z) is calculated as:
where j represents the photons originating at point (x, y, z) in the tissue, and i represents the tissue type inside the geometry. The distance each photon travels within each tissue type, l ij , and the absorption coefficient, µ i a , in each tissue type is used to generate the weight of each photon using Beer's law. In our simulations, two tissue types were used: vasculature and non-vasculature. Therefore, the total travel lengths in vascular (l 1 ), and non-vascular (l 2 ) were saved for each detected fluorescent photon. This process is repeated for every point inside the geometry to build up a three dimensional distribution of signal using photons which arrive at a user specified detector location.
The depth-dependent signal distribution, f (z), which is the probability of the collected signal originating from a depth z in the geometry, was calculated from the signal intensity distribution I d (x, y, z) using the following relation:
The depth-integrated signal distribution, F (z) can then be calculated by integrating f (z) from 0 to z, and represents the amount of signal originating from the first z µm in the geometry. The expression for F (z) is as follows:
Simulations

Comparison of microvasculature and homogeneous geometry
Our first consideration was to analyze the difference in the spatial distribution of the origin of emission between an in vivo microvasculature geometry and a homogeneous tissue with a volume fraction of absorbers. In the microvasculature geometry, a widefield illumination and small detection method was simulated to mimc a single pixel in a typical camera geometry. A 400 µm diameter, slightly diverging (NA = 0.01) cone of light was used as the illumination. The detector was a 50 µm × 50 µm square at the top-center of the geometry. The small detection volume can be thought of as a single pixel in a camera. This illumination and detection scheme will henceforth be referred to as the "camera" scheme.
For each of the three homogeneous tissue geometries, 1%, 5%, and 10% blood volume fraction, simulations were performed using 415nm, 524nm, and 800nm excitation. f (z) and F (z) were calculated from the signal distribution, I d (x, y, z) using Eqns. 2 and 3, and used to compare the homogeneous and microvascular geometries.
Evaluation of different illumination and detection schemes
For each excitation wavelength (415nm, 524nm and 800nm), the microvascular geometry was used for three illumination and detection schemes. The "camera" scheme previously described was used, in addition to the "targeted" scheme and the "confocal" scheme.
The "targeted" method consisted of a 20 µm diameter illumination area and a detector that captured all emission photons exiting the surface of the tissue. This scheme mimics selective illumination of a small area of the tissue and integration of all fluorescent photons exiting the tissue, similar to approaches that utilize structured illumination with single point detectors. The "confocal" method is hybrid of the previous two, which is similar to the scanning confocal method. The illumination source was a 20 µm diameter beam with an NA of 0.01, while the detector was a 50 µm × 50 µm square at the top-center of the geometry.
The results of the three illumination schemes were then compared to determine the effect of choosing a targeted illumination scheme over a wide-field illumination scheme, as well as a wide field detector (i.e. PMT or APD) over a point detector (i.e. camera pixel) based on the desired signal distribution.
To provide a comparison between the schemes, both the depth-dependent and depth-integrated signal distributions for each excitation and emission wavelength pair were calculated according to Eqns. 2 and 3. Additionally, the 3D rendering of the signal distribution for the camera scheme, I d (x, y, z) , was generated to demonstrate the effects of using a widefield illumination method.
Evaluation of fluorescence sampling in single vessels
The objective of the single vessel geometry was to determine the penetration of excitation light into underlying tissue when fluorescence is measured from surface vessels, and thus to determine how much of the captured signal can be attributed to the targeted vessel. As such, the illumination area was a circle with a diameter that matched the diameter of the vessel in each geometry. Vessel diameters of 25, 50, 75, 100, 150, and 200 µm were used, which represents approximately the range of vessel diameters in the rat cortex, excluding capillaries and very large vessels. Simulations were performed using 415nm, 524nm and 800nm illumination and a wide-field detector. Outside of the vessel, a 5% volume fraction of vascularization was used so that a measure of the amount of excitation light penetrating through the vessel could be easily measured. The portion of the signal I d (x, y, z) inside the vessel was divided by the total integrated signal to obtain a value representing the percentage of signal originating from inside the single targeted vessel.
RESULTS
Comparison of microvasculature and homogeneous geometry
The comparison between the microvasculature geometry and the homogeneous tissue geometry can be seen in Fig. 2 . The top row of Fig. 2 shows the depth-dependent signal distribution, f (z), of the collected signal, calculated using Eq. 2. The bottom row of Fig. 2 shows the depth-integrated signal distribution, F (z), of the collected signal as a function of depth-a value of 0.3 at 100 µm, therefore, would mean that 30% of the fluorescence signal originated from the top 100 µm of the geometry.
Measurements of the volume of the microvasculature geometry showed that the approximate volume fraction of blood vessels was 3.5%. Homogenous geometries of 1%, 5%, and 10% for 415nm and 524nm excitation and 5% and 10% for 800nm excitation are shown to demonstrate that the results do not match a realistic geometry in most cases. The results suggest that the accuracy of a bulk-vascularized tissue assumption is strongly dependent on the excitation wavelength of the fluorophore.
The 415 nm excitation case shown in Fig. 2(a-b) shows that the microvasculature geometry model falls between the 1% and 5% homogeneous geometry. The 50 µm × 50 µm detector location is positioned in the center of the illumination ring. The area contains a pial vessel at approximately 40 µm inside the tissue, which explains the peak at 40 µm in the plot of f (z). 524nm and 800nm excitation produced different results. Fig. 2(c-f) shows that with 524nm and 800nm excitation the microvasculature geometry simulations give a depth-dependent signal distribution less than that of even a 10% vascularized homogeneous tissue geometry. While the 524nm excitation still shows shallower penetration than would be expected given the 3.5% vascularized geometry used, the error is less dramatic than the 800nm case. Figure 3 shows the depth dependence of the detected signals for the three imaging geometries. Fig. 3(a-b) shows f (z) and F (z) in the microvasculature geometry using the camera illumination and detection scheme at 415nm, 524nm and 800nm excitation. Figs. 3(c-d) and 3(e-f) show the same values for the targeted and confocal schemes, respectively.
Evaluation of different illumination and detection schemes
From Fig. 3(e-f) , the best spatial localization is obtained when using the confocal illumination and detection scheme. The strong peak at approximately 40 µm in the plots on the bottom row represents an approximately 20 µm wide pial vessel directly below the surface position of the illumination beam and the center of the detector.
Using the targeted scheme, shown in Figs. 3(a-b) , generates a strongly wavelength-dependent signal distribution. When using 415nm excitation, the signal distribution is similar to the distribution obtained when using the confocal illumination and detection scheme. However, when 524nm or 800nm excitation light was used, the first vessel encountered did not represent a significant fraction of the total measured signal.
Lastly, the camera scheme shown in Fig. 3(c-d) , is the least sensitive method of the three to surface vasculature, with only a small fraction of the total collected signal originating from directly under the detector area.
As a visual aide, Fig. 4 shows a 3D rendering of the origin of fluorescence detected in a small area on the surface when using the camera illumination and detection scheme, as generated by weighting each detected photon according to Eq. 1. The total signal was then normalized to generate a 3D distribution of the signal using 1 µm × 1 µm bins. The simulation demonstrates that when a large area on the surface is illuminated, the fluorescence signal collected at the surface can originate not only from deeper in the tissue under the detector area, but also from areas near the surface that are not under the detector: similar to what is seen with source-detector separations.
A 50 µm × 50 µm × 100 µm section of the tissue below the detector was evaluated to determine how much of the signal originated from fluorescent photons emitted from 100 µm below the 50 µm×50 µm detector. At 415nm, 33.2% of the fluorescence originated from 100 µm below the detector surface. At 524nm, 15.6% originated in that area, and at 800nm, 13.2% of the fluorescence originated within the region. When comparing these results to the total amount of fluorescence originating from the first 100 µm of tissue, the fraction of fluorescence originating from below the detector is approximately 50% in all three cases. Fig. 5(c) shows the fraction of the total collected signal which originated inside the 100 µm vessel at each of the three excitation wavelengths. A targeted surface vessel with a diameter of 100 µm, for example, will produce a signal that is 100% representative of the vessel fluorescence at 415nm, 80% representative of vessel fluorescence at 524nm, and 50% representative of vessel fluorescence at 800nm.
Intra-vessel distribution of fluorescence emission
DISCUSSION
Comparison of microvasculature and homogeneous geometry
From Fig. 2 , we found that the microvasculature geometry simulations produce significantly different results than the homogeneous tissue geometry. Additionally, the excitation wavelength is important when considering how the microvasculature geometry is different from the homogeneous geometry. Using 415nm excitation, as in Fig.  2(a-b) , the homogeneous geometry reasonably predicts the depth distribution of emitted fluorescence. However, when 524nm and 800nm excitation were used, as in Fig. 2(c-f) , the homogeneous geometry over-predicted the depth distribution of the emitted fluorescence.
Differences in signal distribution between the microvasculature geometry and the homogeneous tissue geometry can be partially attributed to the large difference between the intra and extra vascular absorption coefficients. Excitation photons experience a small amount of absorption outside of the blood vessels, which allows them to scatter around blood vessels and penetrate deeper into the tissue. The emission photons, being stokes-shifted into the near infrared region for the fluorophores considered here, are not strongly absorbed in any tissue and can return to the surface without much attenuation from absorption.
Additionally, it appears that the depth of penetration in a realistic geometry relative to the homogenous geometry assumption also strongly correlates with the amount of difference between the absorption of blood and contrast agent at the excitation wavelength and the emission wavelength. A large excitation-emission absorption difference, such as the 415nm to 690nm in Pd-porphyrin, causes the depth penetration to be greater than what the homogeneous assumption would predict. A smaller difference, on the other hand, appeared to produce the opposite effect, with the homogeneous tissue assumption significantly over-predicting the depth of the collected signal distribution. These results are likely unique to the case of intravascular fluorophore distributions and have little bearing on previous numerical studies, where the fluorophore is distributed via diffusion into the tissue.
The actual distribution of vasculature with respect to the detector position must also be considered. In 2, the detector is positioned in the center of the geometry, where there are many small pial vessels present, the surface-most one being approximately 40 µm from the surface. This detector position likely has an impact on f (z) and F (z). If the detector were to be placed over a larger vessel that is closer to the surface, the F (z) curve would likely be shifted even more to the left, causing the homogeneous geometry to over-predict the distribution of fluorescence excitation even more.
Evaluation of different illumination and detection schemes
Given the results seen confocal type illumination and detection scheme in 3(e-f), it appears that given a low numerical aperture (NA) beam, surface vasculature can be strongly emphasized by localizing both the illumination and the detection positions, as in the confocal scheme.
In the targeted illumination scheme, shown in Fig. 3(a-b) , the fraction of signal originating from the first vessel encountered was highly dependent on the excitation wavelength. This observation could be useful if stronger sensitivity to surface vasculature is desired, as this can be controlled somewhat with selection of excitation wavelength. With Pd-porphyrin, either the surface vasculature can be emphasized by using 415nm excitation light, or higher depth sensitivity can be obtained by using 524nm excitation light.
Regardless of the excitation wavelength used, the light entering the detector is representative of more than just the vasculature directly below the detector. This is an important observation, as often the surface vasculature will be visible on the camera which is detecting the fluorescence, and it is easy to mistake the signal received as coming from the surface vessels. Fig. 4 provides a good visual aid to explain the peaks in Fig. 2(c) . The peaks at the surface correspond to the signal detected from the surface vasculature under the entire illumination area, while the peaks at 40 µm correspond to the first vessel directly beneath the detector surface. From the results found by analyzing the 50 × 50 × 100 µm box below the detector, the fluorescence originating from below the detector accounts for approximately half of the total fluorescence detected from the first 100 µm, regardless of the wavelength used. From Fig. 3 , the results suggest that techniques which prioritize accurate imaging of microvasculature should aim to focus the excitation light on the tissue of interest. If the excitation light has a small NA (nearly collimated), then the emitted light will represent vasculature at a number of different depths, dependent on the distance between the surface and the first vessel the excitation light meets. In many of the cases in Fig. 3 , for example, the excitation photons scatter down to 40 µm before encountering a blood vessel. Penetration depth is therefore a difficult subject to speak about in absolute terms, as it strongly depends on the location of the vasculature in relation to the source excitation beam. Techniques that utilize depth selection independently of illumination, such as confocal methods, would benefit from taking this observation into consideration.
Intra-vessel distribution of fluorescence emission
At 415nm, seen in Fig. 5(c) , the intra-vessel absorption was high enough to completely prevent the excitation light from penetrating through to deeper tissues. The absorption also prevented the excitation light from being able to sample the entire vessel. This could affect measurements where an average across the vessel diameter would provide a more accurate measurement of a given parameter than just the value near the vessel wall. The 524nm illumination light was able to sample the entire vessel, but at smaller vessel sizes the light also penetrated through the vessel and sampled a significant amount of tissue outside the vessel in question. At 800nm, the results are similar to what to the 524nm excitation case in Fig. 5(b) , though as expected more light is able to penetrate through the vessel. Note that while these results demonstrate that using 415nm illumination can allow for strong emphasis of surface vasculature in the targeted illumination scheme, Fig. 3 also suggests that using this wavelength can allow for emphasized surface vasculature in all three of the illumination and detection schemes evaluated.
CONCLUSION
We have shown that a homogeneous geometry assumption cannot always accurately predict the depth sampling in vascular fluorescence imaging. A more complex model, involving both the difference in absorption between the excitation and emission wavelengths, as well as the difference in absorption coefficients in the fluorescing region compared to the non-fluorescing region is required to provide a more accurate picture of depth penetration.
We also examined three illumination and detection schemes used in fluorescence imaging. The targeted and confocal illumination schemes offer a more focused signal distribution over wide field illumination. Using the confocal illumination and detection scheme in particular offers very strong localization of signal to the surface vasculature, while the wide-area detection in the targeted scheme can provide more depth-weighted signals. Using the camera scheme offers the greatest depth weighting of the three illumination and detection schemes we evaluated, but at the cost of including fluorescence from near the surface over the entire illumination region.
Lastly, we examined intra-vessel sampling and demonstrated that when using an excitation wavelength that is strongly absorbed by blood, our collected signal originates from only the top-surface of the targeted vessels. This may need to be taken into account if using a lifetime imaging method that will produce different results near the vessel walls-a wavelength which is absorbed by blood less may be more useful to provide a signal which is integrated across the vessel diameter.
